Despite decades of research efforts, researchers have yet to reach a consensus on the definition of bullying. There are ambiguities around the conceptualization of bullying relating to the intent, harm, repetitions of an act, and power disparity in episodes of bullying. Practically, the lack of differentiation between bullying and playful teasing as well as between bullying and other types of aggression has made it difficult to accurately measure bullying and derive the prevalence rate. There has been scant attention to how people evaluate an intent, harm, repetitions of an act, and power disparity between bullies and targets. If bullying is a moral issue, it involves people’s moral judgments and cannot be understood solely by empirical descriptions of the behavior. In this paper, I considered how social domain theory can be applied to help understand people’s judgments about bullying behaviors, which, in turn, is helpful in improving our conceptualization of bullying.

Keywords:
Bullying, Cyberbullying, Definitions, Judgment, Reasoning, Social domain theory
This content is only available via PDF.
© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.